Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

recruiting267%
terminated133%

Recent Activity

2 active trials
Showing 3 of 3
terminatedphase_4

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

NCT02721888
recruiting

MR Microstructural Imaging for Prostate Cancer Diagnosis

NCT07249281
recruiting

Validation of an Algorithm for the Diagnosis of Sarcopenic Obesity

NCT06815978

Clinical Trials (3)

Showing 3 of 3 trials
NCT02721888Phase 4

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

Terminated
NCT07249281

MR Microstructural Imaging for Prostate Cancer Diagnosis

Recruiting
NCT06815978

Validation of an Algorithm for the Diagnosis of Sarcopenic Obesity

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3